BD9 is a multibody that targets IL-13 and TSLP, and has potential to treat TH-2-driven inflammatory diseasesBD9 designed ...

COVID-19 testing includes molecular (PCR), antigen (rapid), and antibody (serology) tests, each serving different ...

On May 27, RemeGen Co., Ltd.(688331.SH / 09995.HK) announced that Telitacicept has officially been approved for marketing in ...

A new study from Sir Ganga Ram Hospital reveals that force-feeding lentil-based foods to infants during weaning can lead to ...

The George S. Wise Faculty of Life Sciences, Department of Cell Research and Immunology, Tel Aviv University, Tel Aviv 69978, Israel ...

A team of Ohio State researchers engineered a new antibody that could revolutionize influenza prevention through a nasal spray.

The paper approaches autoimmune encephalitis as a broad category rather than focusing on individual antibody syndromes ... presenting with faciobrachial dystonic seizures, 63% for NMDAR-IgG ...

Channing Laboratory, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, Department of Medical Microbiology and Immunology, Aarhus University, Bartholin Building, ...

The FDA has approved Johnson & Johnson's anti-FcRn antibody, nipocalimab, for the treatment of generalized myasthenia gravis. The drug will be sold under the brand name IMAAVY. This approval ...

Myasthenia gravis is an autoimmune disorder in which antibodies disrupt the communication between nerves and muscles, ...

The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...

Autoimmune diseases develop when the immune system mistakenly attacks the body’s own tissues by recognizing self-antigens as ...